U.S. markets close in 3 hours 48 minutes
  • S&P 500

    3,470.92
    -12.89 (-0.37%)
     
  • Dow 30

    28,528.59
    -77.72 (-0.27%)
     
  • Nasdaq

    11,635.88
    -35.67 (-0.31%)
     
  • Russell 2000

    1,639.84
    +6.03 (+0.37%)
     
  • Crude Oil

    41.03
    +0.15 (+0.37%)
     
  • Gold

    1,911.60
    +5.20 (+0.27%)
     
  • Silver

    24.68
    +0.28 (+1.15%)
     
  • EUR/USD

    1.1792
    +0.0065 (+0.55%)
     
  • 10-Yr Bond

    0.7640
    +0.0200 (+2.69%)
     
  • GBP/USD

    1.2996
    +0.0088 (+0.68%)
     
  • USD/JPY

    105.4200
    +0.0260 (+0.02%)
     
  • BTC-USD

    11,774.88
    +717.87 (+6.49%)
     
  • CMC Crypto 200

    240.12
    +6.46 (+2.76%)
     
  • FTSE 100

    5,884.65
    -34.93 (-0.59%)
     
  • Nikkei 225

    23,671.13
    +260.50 (+1.11%)
     

Five Companies Reach 52-Week Highs

GuruFocus.com
·7 mins read

According to the GuruFocus list of 52-week highs, these Guru stocks have reached their 52-Week Highs.

Illumina Inc. reached the 52-week high of $399.01

Illumina (NASDAQ:ILMN) provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables. Illumina's high-throughput technology enables whole-genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 17% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology and rare-disease screening) and whole-genome sequencing.


The price of Illumina Inc. shares has reached $399.01, which is 0.2% off the 52-week high of $400.00. Illumina Inc. has a market cap of $58.65 billion; its shares were traded around $399.01 with a price-earnings ratio of 62.84 and a price-sales ratio of 16.67. Illumina Inc. had an annual average earnings growth of 23.20% over the past 10 years. GuruFocus rated Illumina Inc. the business predictability rank of 5-star.

Illumina, Inc. recently announced its financial results for the first quarter of the fiscal year 2020. Revenue of $859 million marked a 2% increase compared to $846 million in the first quarter of 2019. GAAP earnings per share was $1.17 compared to $1.57 for the first quarter of 2019.

President and CEO Francis A. Desouza sold 3,000 shares of Illumina stock on July 1, 2020 at the price of $366.65 per share. The price of the stock has increased by 8.83% since.

Carvana Co. reached the 52-week high of $145.14

Carvana Co. (NYSE:CVNA) is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage.

The price of Carvana Co. shares has reached $145.14, which is 1.2% off the 52-week high of $146.81. Carvana Co. has a market cap of $24.7 billion; its shares were traded around $144.99 with a price-sales ratio of 1.67.

Carvana Co. recently announced financial results for the quarter ended March 31. Retail units sold were 52,427, an increase of 43% year over year. Revenue was $1.098 billion, an increase of 45% year over year.

Bio-Techne Corp. reached the 52-week high of $281.59

Bio-Techne Corp. (NASDAQ:TECH) is a life science manufacturer supplying consumables and instruments for the pharma, biotech, academic and diagnostic markets. The protein sciences division's key products (78% of sales) include proteins, antibodies and assays as well as equipment and associated consumables for protein characterization and analysis. The remaining revenue in the diagnostics and genomics segment is roughly split between manufacturing creates controls, calibrators and reagents for diagnostic manufacturers combined with proprietary molecular and genetic testing kits.

The price of Bio-Techne Corp. shares has reached $281.59, which is 1.8% off the 52-week high of $286.68. Bio-Techne Corp. has a market cap of $10.76 billion; its shares were traded around $281.59 with a price-earnings ratio of 59.54 and a price-sales ratio of 14.68. The trailing 12-month dividend yield of Bio-Techne Corp. stocks is 0.45%. The forward dividend yield of Bio-Techne Corp. stocks is 0.45%. Bio-techne Corp. had an annual average earnings growth of 2.20% over the past 10 years. GuruFocus rated Bio-Techne Corp. the business predictability rank of 3-star.

Bio-Techne Corporation recently reported its financial results for the fiscal third quarter ended March 31. Third quarter organic revenue increased by 6% to $194.7 million. GAAP earnings per share were $0.92 versus $1.15 one year ago.

Chief Financial Officer James Hippel sold 24,079 shares of Bio-Techne stock on July 7, 2020 at the price of $271.59 per share. The price of the stock has increased by 3.68% since.

Church & Dwight Co. Inc. reached the 52-week high of $84.08

Church & Dwight (NYSE:CHD) is the leading producer of baking soda in the world. Around a dozen of its products are sold under the Arm & Hammer brand umbrella, such as baking soda, toothpaste, cat litter and carpet cleaner. Its mix also includes Xtra, Trojan, OxiClean, First Response, Nair, L'il Critters/Vitafusion and Orajel.

The price of Church & Dwight Co. Inc. shares has reached $84.08, which is 1.5% off the 52-week high of $85.36. Church & Dwight Co. Inc. has a market cap of $20.67 billion; its shares were traded around $84.08 with a price-earnings ratio of 31.49 and a price-sales ratio of 4.73. The trailing 12-month dividend yield of Church & Dwight Co. Inc. stocks is 1.10%. The forward dividend yield of Church & Dwight Co. Inc. stocks is 1.13%. Church & Dwight Co. Inc. had an annual average earnings growth of 9.00% over the past 10 years. GuruFocus rated Church & Dwight Co. Inc. the business predictability rank of 5-star.

Church & Dwight Co. Inc. recently reported first quarter 2020 earnings per share of $0.92, a 31.4% increase year over year. First quarter net sales grew 11.5% to $1.16 billion.

Executive Vice President Steven P. Cugine sold 20,800 shares of Church and Dwight stock on July 10, 2020 at the price of $82.89 per share. The price of the stock has increased by 1.44% since.

Skyworks Solutions Inc. reached the 52-week high of $137.80

Skyworks Solutions (NASDAQ:SWKS) produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in non-handset applications such as wireless routers, medical devices and automobiles.

The price of Skyworks Solutions Inc. shares has reached $137.80, which is 0.3% off the 52-week high of $138.22. Skyworks Solutions Inc. has a market cap of $22.99 billion; its shares were traded around $137.80 with a price-earnings ratio of 29.86 and a price-sales ratio of 7.28. The trailing 12-month dividend yield of Skyworks Solutions Inc. stocks is 1.27%. The forward dividend yield of Skyworks Solutions Inc. stocks is 1.27%. Skyworks Solutions Inc. had an annual average earnings growth of 27.60% over the past 10 years. GuruFocus rated Skyworks Solutions Inc. the business predictability rank of 2.5-star.

Skyworks Solutions, Inc. recently reported second fiscal quarter results for the period ended March 27, 2020. Revenue for the second fiscal quarter was $766.1 million. On a GAAP basis, earnings per share was $1.06.

President and Chief EEO Liam Griffin sold 9,125 shares of Skyworks Solutions stock on July 15, 2020, at the price of $130.42 per share. The price of the stock has increased by 5.66% since.

Note: I do not own the stocks discussed.

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

This article first appeared on GuruFocus.